Now showing items 1-1 of 1

  • Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2. 

    Ferner, RE; Shaw, A; Evans, DG; McAleer, D; Halliday, D; Parry, A; Raymond, FL; Durie-Gair, J; Hanemann, CO; Hornigold, R; Axon, P; Golding, JF (Germany, 2014-05)
    Advances in molecular biology have resulted in novel therapy for neurofibromatosis 2-related (NF2) tumours, highlighting the need for robust outcome measures. The disease-focused NF2 impact on quality of life (NFTI-QOL) ...

All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
@mire NV